AZ: Ask your Representative to vote YES on Step Therapy Reform


  • Your State Representative or Representatives


*Required fields


Vote YES on SB 1270

Dear Representative  [Decision Maker],

I'm writing today as your constituent to ask you to vote YES on SB 1270 to ensure prescription drug decisions are kept between a doctor and their patient and ensure that when step therapy is used in Arizona it is safe for patients, clinically grounded, and, transparent to patients and health care providers.

Step therapy often called "fail first," is a process that requires patients to try and fail on one or more medications chosen by their insurer before they can access the optimal treatment recommended and prescribed by their healthcare provider. There is currently no clear step therapy exemption process in Arizona.

The current one-size-fits-all approach to controlling health care costs can lead to unnecessary delays, even denials, of care. This often causes Arizona patients' health to deteriorate as they try and fail on medications that don't work for them. Requiring a patient to follow a step therapy protocol may have adverse and even dangerous consequences for the patient who may either not realize a benefit from taking a prescription drug, suffer harm from taking the wrong drug, and/or abandon their treatment.

SB1270 protects patients by ensuring that fail first protocols are based on clinical guidelines developed by independent experts, establishing a basic framework for when it is medically appropriate to exempt patients from fail first, and ensuring that the exception process is transparent and accessible to patients and health care providers.

I support this legislation because it appropriately balances the competing goals of protecting patients from adverse health outcomes and controlling healthcare costs.

I hope I can count on you to take a stand for cancer patients and make sure they get the medicine they need, when they need it, by voting YES on SB1270.

[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]